INVO Bioscience (INVO) Stock Price, News & Analysis

Company Overview

INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.

Key Stats

• Today's Range: $0.82 to $0.90
• 50-Day Range: $0.84 to $2.33
• 52-Week Range: $0.63 to $3.50
• Volume: 117,277 shs
• Average Volume: 1.59 million shs
• Market Capitalization: $3.33 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

INVO Stock Analysis - Frequently Asked Questions

How have INVO shares performed this year?

INVO Bioscience's stock was trading at $0.81 on January 1st, 2025. Since then, INVO stock has increased by 8.1% and is now trading at $0.8755.

How were INVO Bioscience's earnings last quarter?

INVO Bioscience, Inc. (NASDAQ:INVO) posted its earnings results on Monday, November, 15th. The company reported ($4.80) earnings per share for the quarter, missing analysts' consensus estimates of ($4.00) by $0.80. The firm had revenue of $0.22 million for the quarter, compared to the consensus estimate of $0.25 million.

When did INVO Bioscience's stock split?

INVO Bioscience shares reverse split on the morning of Thursday, July 27th 2023.The 1-20 reverse split was announced on Thursday, July 27th 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, July 27th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

How do I buy shares of INVO Bioscience?

Shares of INVO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of INVO Bioscience own?

Based on aggregate information from My MarketBeat watchlists, some other companies that INVO Bioscience investors own include NVIDIA (NVDA), NIO (NIO), Tesla (TSLA), Meta Platforms (META), Nikola (NKLA), Broadcom (AVGO) and Bilibili (BILI).

Company Calendar

• Last Earnings: 11/15/2021
• Today: 7/03/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: N/A
• Current Symbol: NASDAQ:INVO
• CIK: 1417926
• Web: www.invobioscience.com
• Phone: (978) 878-9505
• Fax: N/A
• Employees: 25
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$8.03 million
• Net Margins: -122.79%
• Pretax Margin: -122.32%
• Return on Equity: N/A
• Return on Assets: -36.94%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.30
• Quick Ratio: 0.27

Sales & Book Value

• Annual Sales: $5.77 million
• Price / Sales: 0.56
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($2.06) per share
• Price / Book: -0.41

Miscellaneous

• Outstanding Shares: 3,809,000
• Free Float: 3,769,000
• Market Cap: $3.22 million
• Optionable: No Data
• Beta: 1.43